Shared pathways of osteoblast mitogenesis induced by amylin, adrenomedullin, and IGF-1

Biochemical and Biophysical Research Communications

Volumn 318, Issue 1, 2004, Pages 240-246

  Cornish, Jillian ^a   Grey, Andrew ^a   Callon, Karen E ^a   Naot, Dorit ^a   Hill, Bernadine L ^a   Lin, Cindy Q X ^a   Balchin, Leanne M ^a   Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Calcitonin like; IGF 1 receptor; In vitro; MAP kinase; Osteoblast

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; ADRENOMEDULLIN RECEPTOR BLOCKING AGENT; AMYLIN; AMYLIN RECEPTOR; AMYLIN RECEPTOR BLOCKING AGENT; RECEPTOR BLOCKING AGENT; RECEPTOR PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; FETUS; MITOGENESIS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; SIGNAL TRANSDUCTION;

ADRENOMEDULLIN; AMYLOID; ANIMALS; CELL DIVISION; CELLS, CULTURED; ENZYME ACTIVATION; FIBROBLASTS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MITOGENS; OSTEOBLASTS; PEPTIDES; RATS; RECEPTOR, IGF TYPE 1; RECEPTORS, PEPTIDE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 1942424868     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.04.020     Document Type: Article

References (19)

1. Cornish J., Callon K.E., Cooper G.J.S., Reid I.R. Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochem. Biophys. Res. Commun. 207:1995;133-139.
2. Cornish J., Callon K.E., King A.R., Cooper G.J., Reid I.R. Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice. Am. J. Physiol. 275:1998;E694-E699.
3. Cornish J., Callon K.E., Bava U., Kamona S.A., Cooper G.J., Reid I.R. Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone. 29:2001;162-168.
4. Cornish J., Callon K.E., Coy D.H., Jiang N.-Y., Xiao L., Cooper G.J.S., Reid I.R. Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo. Am. J. Physiol. 273:1997;E1113-E1120.
5. Naot D., Callon K.E., Grey A., Cooper G.J.S., Reid I.R., Cornish J. A potential role for adrenomedullin as a local regulator of bone growth. Endocrinology. 142:2001;1849-1857.
6. Bonewald L.F., Dallas S.L. Role of active and latent transforming growth factor beta in bone formation. J. Cell. Biochem. 55:1994;350-357.
7. Zapf J., Froesch E.R. Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological role. Horm. Res. 24:1986;121-130.
8. Pfeilschifter J., Oechsner M., Naumann A., Gronwald R.G., Minne H.W., Ziegler R. Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor beta. Endocrinology. 127:1990;69-75.
9. Huang B.K., Golden L.A., Tarjan G., Madison L.D., Stern P.H. Insulin-like growth factor I production is essential for anabolic effects of thyroid hormone in osteoblasts. J. Bone Miner. Res. 15:2000;188-197.
10. McCarthy T.L., Ji C., Centrella M. Links among growth factors, hormones, and nuclear factors with essential roles in bone formation. Crit. Rev. Oral Biol. Med. 11:2000;409-422.
11. Miyakoshi N., Kasukawa Y., Linkhart T.A., Baylink D.J., Mohan S. Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. Endocrinology. 142:2001;4349-4356.
12. Sell C., Dumenil G., Deveaud C., Miura M., Coppola D., DeAngelis T., Rubin R., Efstratiadis A., Baserga R. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol. 14:1994;3604-3612.
13. Grey A., Banovic T., Naot D., Hill B., Callon K., Reid I., Cornish J. Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not P42/44 mitogen-activated protein kinases. Endocrinology. 142:2001;1098-1106.
14. Grey A., Chen Q., Xu X., Callon K., Cornish J. Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells. Endocrinology. 144:2003;4886-4893.
15. Vignery A., McCarthy T.L. The neuropeptide calcitonin gene-related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblasts. Bone. 18:1996;331-335.
16. Cornish J., Naot D. Amylin and adrenomedullin: novel regulators of bone growth. Curr. Pharm. Des. 8:2002;2009-2021.
17. LeRoith D., Werner H., Beitner-Johnson D., Roberts C.T. Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16:1995;143-163.
18. Du J., Sperling L.S., Marrero M.B., Phillips L., Delafontaine P. G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth muscle cells: thrombin- and angiotensin II-induced tyrosine phosphorylation of insulin receptor substrate-1 and insulin-like growth factor 1 receptor. Biochem. Biophys. Res. Commun. 218:1996;934-939.
19. Dalle S., Ricketts W., Imamura T., Vollenweider P., Olefsky J.M. Insulin and insulin-like growth factor I receptors utilize different G protein signaling components. J. Biol. Chem. 276:2001;15688-15695.